RICHARD A. MILLER - 06 May 2024 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role: President and CEO, Director
Signature: /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Issuer symbol: CRVS
Transactions as of: 06 May 2024
Net transactions value: +$1,000,000
Form type: 4
Filing time: 07 May 2024, 17:05:52 UTC
Previous filing: 08 Dec 2023
Next filing: 14 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRVS	Common Stock	Purchase	$1,000,000	+577,634		$1.73	577,634	06 May 2024	Direct
holding	CRVS	Common Stock						1,490,119	06 May 2024	By Trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRVS	Warrant (Right to Buy)	Purchase		+559,073			559,073	06 May 2024	Common Stock	559,073	$3.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
F2	Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.